Sri Lanka Society of Gastroenterology Collaborative Hepatocellular Carcinoma Snapshot Audit ( SLSG CARSA ): A Nationwide, Cross‐Sectional Snapshot Study
Cancer Reports · 2026-11 · 9 (11)
DOI: 10.1002/cnr2.70746 ↗Abstract
ABSTRACT Background and Aims Sri Lanka lacks nationwide data on the incidence and characteristics of hepatocellular carcinoma (HCC); there is no prospective national HCC registry, and the only published clinical series comes from a single tertiary centre. We conducted a three‐month, nationwide, snapshot cross‐sectional survey to address this gap. Methods We invited clinicians at all state‐sector and major private‐sector institutions providing gastroenterology, gastrointestinal surgery, or oncology services in the nine provinces of Sri Lanka to report new cases diagnosed between June and August 2024. Diagnosis required either dynamic contrast‐enhanced imaging in cirrhotic patients or histology in non‐cirrhotic cases, or when imaging was inconclusive. We collected data on demographics, performance status, liver disease, risk factors, tumour characteristics and treatment approaches using a REDCap electronic case‐report form with built‐in validation and query resolution. Age‐specific counts were multiplied by four to annualise the three‐month observation and standardised to the WHO World Standard Population. Confidence intervals (CI) were derived from the observed (unannualised) case count, and sensitivity analyses examined seasonality and incomplete ascertainment. Apart from the incidence estimates, the analysis was descriptive, and no hypothesis testing was undertaken. The study is reported in accordance with STROBE. Results A total of 140 patients were included. The age‐standardised incidence rate was 2.51/100000 per year (95% CI 2.11–2.97; crude rate 2.54/100000, 95% CI 2.13–2.99). Most patients (78.6%) were male, with a mean age of 67.4 years. Key findings were as follows: the most frequently recorded risk factors were diabetes (66.4%) and unsafe alcohol use (62.9%); 85.7% had underlying cirrhosis, mostly Child‐Turcotte‐Pugh class A (62.5%); 43.8% presented with single nodules ( n = 137), predominantly 2–5 cm (45.5%; n = 134); 16.4% showed tumour invasion and 12.9% had extra‐hepatic spread; most cases were BCLC stages A (27.9%) or B (30.7%). No positive HBsAg or anti‐HCV results were documented among those tested. Only 46.4% of cases were recorded as screen‐detected, and an initial treatment decision was recorded for only 55.0% of cases. Conclusion This survey provides the first national estimate of HCC incidence in Sri Lanka, approximately twice the previous estimate. Because the earlier figure was derived by modelling in the absence of national surveillance, this difference should be interpreted as evidence of a previously underestimated burden, at least partly attributable to improved case ascertainment, rather than as a demonstrated temporal rise. HCC primarily affects older males with cirrhosis; most patients presented with preserved liver function and moderately sized single tumours at BCLC stages A/B. Strengthened national surveillance, structured early detection strategies and a prospective national HCC registry are needed.
EUVIMED